<html>
<head>PUBMED IDs for CD304</head>
<body bgcolor='#C5F0F2'><h1>CD304</h1><a href='https://pubmed.ncbi.nlm.nih.gov/21487112/'>New markers for minimal residual disease detection in acute lymphoblastic leukemia.</a> August 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22052678/'>CD304 is preferentially expressed on a subset of B-lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometry.</a> September 29  2011<br></body></html>
